DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kayexalate (Sodium Polystyrene Sulfonate) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kayexalate (Sodium Polystyrene Sulfonate) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-08

Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Condition Aggravated, Cardiomyopathy, Bladder Cancer, Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Diamicron
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Perindopril Erbumine
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Prazosin HCL
    Indication: Hypertension
    End date: 2010-02-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29

Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Bladder Cancer

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diamicron
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Prazosin HCL
    Indication: Hypertension
    End date: 2010-02-01

Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Perindopril Erbumine
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-19

Patient: 56 year old male

Reactions: Bladder Transitional Cell Carcinoma Stage II, Cardiomyopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diamicron (Gliclazide)
    Dosage: 30 mg, qd, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Perindopril Erbumine
    Dosage: 2.5 mg
    Start date: 2009-12-01

Aceon
    Dosage: 2.5 mg,qd,oral
    Administration route: Oral

Bisoprolol Fumarate
    Dosage: 2.5 mg, qd, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Allopurinol
    Dosage: 300 mg, qd, oral
    Administration route: Oral
    Indication: Hyperuricaemia

Fenofibrate
    Dosage: 200 mg, qd, oral
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Januvia
    Dosage: 100 mg, qd, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Kayexalate
    Dosage: 1 unit every 2 weeks, oral
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Aspirin
    Dosage: 75 mg, qd, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Actos
    Dosage: 30 mg, qd, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Minirin
    Dosage: 100 ug, tid, oral
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Prazosin HCL
    Dosage: 5 mg, qd, oral
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01



Possible Kayexalate side effects in 56 year old male

Reported by a individual with unspecified qualification from France on 2012-03-13

Patient: 56 year old male

Reactions: Condition Aggravated, Cardiomyopathy, Bladder Transitional Cell Carcinoma Stage II, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Fenofibrate
    Dosage: 200 mg, before 2006, oral
    Administration route: Oral
    Indication: Hypertriglyceridaemia
    Start date: 2006-01-01

Diamicron (Gliclazide) Tablet 30 MG
    Dosage: 30 mg, before 2006, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-01-01

Allopurinol
    Dosage: 300 mg, before 2006, oral
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2006-01-01

Januvia
    Dosage: 100 mg, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Actos
    Dosage: 30 mg, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Perindopril Erbumine
    Dosage: 2.5 mg, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Aspirin
    Dosage: 75 mg, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Bisoprolol Fumarate
    Dosage: 2.5 mg, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Desmopressin Acetate
    Dosage: 300 ug, oral
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Prazosin HCL
    Dosage: oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-01-01
    End date: 2010-02-01

Kayexalate
    Dosage: oral
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01



Possible Kayexalate side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-09

Patient: male

Reactions: Type 2 Diabetes Mellitus, Bladder Cancer Stage II, Cardiac Failure, Congestive Cardiomyopathy, Cardiomyopathy, Appendicitis, Hyperuricaemia, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Prazosin HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01

Diamicron
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2010-03-30

Prazosin HCL
    Indication: Congestive Cardiomyopathy

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Perindopril Erbumine
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Kayexalate
    Indication: Congestive Cardiomyopathy

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Other drugs received by patient: Metformin HCL; Victoza



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07

Patient: 56 year old male

Reactions: Bladder Transitional Cell Carcinoma Stage II

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Actos
    Administration route: Oral
    Start date: 2006-03-01
    End date: 2010-02-01

Diamicron
    Administration route: Oral

Metformin HCL

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Januvia
    Administration route: Oral
    Start date: 2009-10-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Perindopril Erbumine
    Administration route: Oral
    Start date: 2009-12-01

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Bisoprolol Fumarate
    Administration route: Oral
    Start date: 2009-12-01

Aspirin
    Administration route: Oral
    Start date: 2009-12-01

Prazosin HCL
    Administration route: Oral
    End date: 2010-02-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02

Patient: 56 year old male

Reactions: Bladder Transitional Cell Carcinoma Stage II

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prazosin HCL
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01

Bisoprolol Fumarate
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Januvia
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Diamicron
    Dosage: 30 mg, 1x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Perindopril Erbumine
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Aspirin
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Kayexalate
    Dosage: 1 df, 2x/week
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Minirin
    Dosage: 100 ug, 3x/day
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Actos
    Dosage: 30 mg, 1x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Fenofibrate
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Allopurinol
    Dosage: 300 mg, 1x/day
    Administration route: Oral
    Indication: Hyperuricaemia



Possible Kayexalate side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02

Patient: male

Reactions: Bladder Cancer Stage II, Cardiac Failure, Cardiomyopathy, Appendicitis, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diamicron
    Administration route: Oral
    Indication: Pain
    End date: 2010-03-30

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Perindopril Erbumine
    Dosage: 100 mcg thrice
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 1999-12-01

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Prazosin HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 1999-12-01

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Other drugs received by patient: Victoza; Metformin HCL



Possible Kayexalate side effects in 93 year old female

Reported by a physician from Japan on 2011-12-01

Patient: 93 year old female

Reactions: Urinary Tract Infection, Pseudomembranous Colitis, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kayexalate
    Administration route: Oral
    Start date: 2011-06-06
    End date: 2011-07-09

Lasix
    Administration route: Oral
    Start date: 2011-06-06
    End date: 2011-07-09

Other drugs received by patient: Allopurinol; ALL Other Therapeutic Products; Erispan; Amlodipine; Atorvastatin



Possible Kayexalate side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-11-01

Patient: 69 year old female, weighing 69.5 kg (152.9 pounds)

Reactions: Rhabdomyolysis, Renal Failure Acute, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Kayexalate

Other drugs received by patient: Insulatard NPH Human; Irbesartan; Sectral; Atorvastatin Calcium; Depakote; Acarbose; Imovane



Possible Kayexalate side effects in 45 year old male

Reported by a physician from Japan on 2011-10-24

Patient: 45 year old male, weighing 52.0 kg (114.4 pounds)

Reactions: Interstitial Lung Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Allopurinol
    Dosage: daily dose 100 mg
    Administration route: Oral
    Indication: Hyperuricaemia

Calcium Carbonate
    Dosage: daily dose 3000 mg
    Administration route: Oral
    Indication: Hyperphosphataemia

Kayexalate
    Dosage: daily dose 15 g
    Administration route: Oral
    Indication: Hyperkalaemia

Cinacalcet Hydrochloride
    Dosage: daily dose 25 mg
    Administration route: Oral
    Indication: Hyperparathyroidism Secondary

Sevelamer Hydrochloride
    Dosage: daily dose 2250 mg
    Administration route: Oral
    Indication: Hyperphosphataemia

Nexavar
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Renal Cell Carcinoma
    Start date: 2011-05-12
    End date: 2011-05-15

Ticlopidine HCL
    Dosage: daily dose 200 mg
    Administration route: Oral

Zantac
    Dosage: daily dose 300 mg
    Administration route: Oral
    Indication: Gastritis



Possible Kayexalate side effects in 79 year old male

Reported by a physician from Japan on 2011-10-18

Patient: 79 year old male, weighing 51.0 kg (112.2 pounds)

Reactions: Bradycardia, Constipation, Hypokalaemia, Myopathy

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Kayexalate

Other drugs received by patient: Paxil; Acetanol; Magnesium Sulfate; Daikentyuto; Ferrous Sulfate TAB; Calcium Polystyrene Sulfonate; Aspirin; Captopril; Dogmatyl; Adalat; Juzentaihoto



Possible Kayexalate side effects in 93 year old female

Reported by a physician from Japan on 2011-10-10

Patient: 93 year old female

Reactions: Haemoglobin Decreased, Urinary Tract Infection, Pseudomembranous Colitis, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lasix
    Administration route: Oral
    Start date: 2011-06-06
    End date: 2011-07-07

Kayexalate
    Administration route: Oral
    Start date: 2011-06-06
    End date: 2011-07-07

Other drugs received by patient: Allopurinol; ALL Other Therapeutic Products; Amlodipine; Erispan; Atorvastatin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017